Chief Financial Officer Sandercock Brett exercised 2,000 units of ResMed Common Stock at a strike of $101.64 and sold $742,620 worth of ResMed Common Stock (3,000 units at $247.54), decreasing direct ownership by 1% to 85,745 units (SEC Form 4)
Health Care